UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.01B |
| 2 |
Microsoft
MSFT
|
+$922M |
| 3 |
Amazon
AMZN
|
+$646M |
| 4 |
Tesla
TSLA
|
+$554M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$496M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$1.04B |
| 2 |
Linde
LIN
|
+$949M |
| 3 |
ExxonMobil
XOM
|
+$313M |
| 4 |
VMW
VMware, Inc
VMW
|
+$217M |
| 5 |
NVIDIA
NVDA
|
+$205M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.4% |
| 2 | Healthcare | 13.37% |
| 3 | Consumer Discretionary | 11.23% |
| 4 | Financials | 10.99% |
| 5 | Communication Services | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MODN
1926
DELISTED
MODEL N, INC.
MODN
| $957K | ﹤0.01% |
39,187
-7,135
| -15% | -$212K |
|
|
THR
1927
DELISTED
Thermon Group Holdings
THR
| $951K | ﹤0.01% |
34,615
| – | – |
|
|
MCW
1928
DELISTED
Mister Car Wash
MCW
| $950K | ﹤0.01% |
172,494
+83,924
| +95% | +$641K |
|
1929
Simulations Plus
SLP
$369M
| $950K | ﹤0.01% |
22,777
| – | – |
|
1930
Ligand Pharmaceuticals
LGND
$5.76B
| $943K | ﹤0.01% |
15,739
-2,912
| -16% | -$192K |
|
1931
TETRA Technologies
TTI
$1.14B
| $935K | ﹤0.01% |
146,479
+96,299
| +192% | +$496K |
|
1932
Adaptive Biotechnologies
ADPT
$3.59B
| $934K | ﹤0.01% |
171,292
+48,375
| +39% | +$320K |
|
|
VBTX
1933
DELISTED
Veritex Holdings
VBTX
| $933K | ﹤0.01% |
51,976
-2,948
| -5% | -$56.9K |
|
1934
Central Pacific Financial
CPF
$1.02B
| $932K | ﹤0.01% |
55,855
+19,209
| +52% | +$328K |
|
|
OPTU
1935
Optimum Communications Inc
OPTU
$298M
| $931K | ﹤0.01% |
284,678
-133,721
| -32% | -$431K |
|
1936
Forestar Group
FOR
$1.44B
| $929K | ﹤0.01% |
34,502
+21,583
| +167% | +$595K |
|
1937
Methode Electronics
MEI
$496M
| $926K | ﹤0.01% |
40,524
-9,736
| -19% | -$290K |
|
1938
TriCo Bancshares
TCBK
$1.84B
| $922K | ﹤0.01% |
28,799
+1,886
| +7% | +$66.1K |
|
|
BRKL
1939
DELISTED
Brookline Bancorp
BRKL
| $921K | ﹤0.01% |
101,061
| – | – |
|
|
STEL
1940
DELISTED
Stellar Bancorp
STEL
| $920K | ﹤0.01% |
43,138
+1,986
| +5% | +$45.3K |
|
1941
Monro
MNRO
$383M
| $913K | ﹤0.01% |
32,876
-3,428
| -9% | -$118K |
|
1942
Ichor Holdings
ICHR
$2.62B
| $912K | ﹤0.01% |
29,461
+2,903
| +11% | +$99.4K |
|
1943
Phreesia
PHR
$663M
| $912K | ﹤0.01% |
48,819
+5,094
| +12% | +$137K |
|
1944
CRA International
CRAI
$1.16B
| $910K | ﹤0.01% |
9,035
-2,079
| -19% | -$218K |
|
|
SAGE
1945
DELISTED
Sage Therapeutics
SAGE
| $907K | ﹤0.01% |
44,077
| – | – |
|
1946
Dutch Bros
BROS
$9.03B
| $905K | ﹤0.01% |
38,943
+17,471
| +81% | +$498K |
|
1947
Innoviva
INVA
$1.55B
| $905K | ﹤0.01% |
69,658
-5,022
| -7% | -$65.2K |
|
1948
Banc of California
BANC
$3.03B
| $902K | ﹤0.01% |
72,899
+37,074
| +103% | +$472K |
|
1949
ANI Pharmaceuticals
ANIP
$1.8B
| $902K | ﹤0.01% |
15,536
+5,383
| +53% | +$311K |
|
1950
Janus International
JBI
$700M
| $902K | ﹤0.01% |
84,300
+9,274
| +12% | +$102K |
|
Similar funds
UBS AM's Q3 2023 Portfolio in Review
As of Q3 2023, UBS AM held 2,762 positions worth $223B, up 8.1% from $206B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
UBS AM deployed $7.28B of net new capital in Q3 2023, opening 89 new positions and adding to 1,400 existing holdings. Its largest new stake was Kenvue: 8,680,819 shares worth $174M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Abbott, an estimated $1.04B trimmed.
- UBS AM's largest Q3 2023 buy was Kenvue: 8,680,819 shares worth $174M.
- UBS AM added most to Apple in Q3 2023, an estimated $1.01B increase.
- UBS AM's biggest Q3 2023 reduction was Abbott, cutting an estimated $1.04B.
- UBS AM fully exited World Wrestling Entertainment in Q3 2023, selling an estimated $128M.
- UBS AM's ten largest holdings make up 26% of its $223B portfolio in Q3 2023.
- UBS AM opened 89 new positions and closed 174 in Q3 2023.
- UBS AM's portfolio value rose 8.1% quarter-over-quarter to $223B.
Based on UBS AM's 13F filing for Q3 2023, filed 13 Nov 2023.